Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TECNERGY: DMF for Fatigue in RRMS
NCT02090348Phase 4Withdrawn
- Sponsor
- Biogen
- Start
- Jun 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dimethyl fumarate in relapsing-remitting multiple sclerosis (RRMS), sponsored by Biogen. Planned start Jun 2015; status: withdrawn.
02
Drugs
dimethyl fumarate
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT02090348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090348.